on VALNEVA (EPA:VLA)
Valneva Engages Investors at J.P. Morgan Healthcare Conference
Valneva SE, a company specializing in vaccines, is set to meet with investors during the 44th Annual J.P. Morgan Healthcare Conference from January 12-14, 2026, in San Francisco. The meetings will be led by CEO Thomas Lingelbach and CFO Peter Bühler, focusing on upcoming developments such as the pivotal data release for Valneva's Lyme disease vaccine, projected for the first half of this year. Discussions will also cover the commercial portfolio of vaccines.
The conference provides a platform for Valneva to engage with existing shareholders and potential institutional investors interested in its specialized vaccine solutions. Analysts and investors can arrange one-on-one meetings by contacting Valneva's investor relations.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALNEVA news